Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling

Anabolic hormones, mechanical loading, and the obese protein leptin play separate roles in maintaining bone mass. We have previously shown that leptin, as well as its receptor, are expressed by normal human osteoblasts. Consequently, we have investigated how leptin affects proliferation, differentiation, and apoptosis of human osteoblasts. Iliac crest osteoblasts, incubated with either leptin (100 ng/ml), calcitriol (1,25(OH)2D3; 10−9 M) or 1–84 human parathyroid hormone (PTH; 10−8 M), were cultured for 35 consecutive days and assayed for expression of various differentiation‐related marker genes (as estimated by RT‐PCR), de novo collagen synthesis, proliferation, in vitro mineralization, and osteoclast signaling. The effects of leptin on protection against retinoic acid (RA; 10−7 M) induced apoptosis, as well as transition into preosteocytes, were also tested. Leptin exposure enhanced cell proliferation and collagen synthesis over both control condition and PTH exposure. Leptin inhibited in vitro calcified nodule production after 1–2 weeks in culture, however, subsequent to 4–5 weeks, leptin significantly stimulated mineralization. The mineralization profile throughout the entire incubation period was almost undistinguishable from the one induced by PTH. In comparison, 1,25(OH)2D3 generally reduced proliferation and collagen production rates, whereas mineralization was markedly enhanced. Leptin exposure (at 2 and 5 weeks) significantly enhanced the expression of TGFβ, IGF‐I, collagen‐Iα, ALP, and osteocalcin mRNA. Leptin also protected against RA‐induced apoptosis, as estimated by soluble DNA fractions and DNA laddering patterns subsequent to 10 days of culture. The expression profiles of Bax‐α and Bcl‐2 mRNAs indicated that leptin per se significantly protected against apoptosis throughout the entire incubation period. Furthermore, the osteoblast marker OSF‐2 was diminished, whereas the CD44 osteocyte marker gene expression was stimulated, indicating a transition into preosteocytes. In terms of osteoclastic signaling, leptin significantly augmented the mRNA levels of both interleukin‐6 (IL‐6) and osteoprotegerin (OPG). In summary, continuous leptin exposure of iliac crest osteoblasts, promotes collagen synthesis, cell differentiation and in vitro mineralization, as well as cell survival and transition into preosteocytes. Leptin may also facilitate osteoblastic signaling to the osteoclast. © 2002 Wiley‐Liss, Inc.

[1]  A. Goulding,et al.  Plasma Leptin Values in Relation to Bone Mass and Density and to Dynamic Biochemical Markers of Bone Resorption and Formation in Postmenopausal Women , 1998, Calcified Tissue International.

[2]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[3]  L. Hood,et al.  OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. , 1998, Journal of immunology.

[4]  R. Unger,et al.  Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. , 2001, Diabetes.

[5]  C. Drevon,et al.  Pharmacological interference with transcriptional control of osteoblasts: a possible role for leptin and fatty acids in maintaining bone strength and body lean mass. , 2001, Current pharmaceutical design.

[6]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[7]  J. Aubin,et al.  OSTEOBLASTIC CELL LINEAGE , 1993 .

[8]  J. Fleet Leptin and bone: does the brain control bone biology? , 2009, Nutrition reviews.

[9]  G. Stein,et al.  Transcriptional control of osteoblast growth and differentiation. , 1996, Physiological reviews.

[10]  S. Melmed,et al.  Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  C. Drevon,et al.  Leptin Is Expressed in and Secreted from Primary Cultures of Human Osteoblasts and Promotes Bone Mineralization , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  L. Sumoy,et al.  Identification of a spatially specific enhancer element in the chicken Msx-2 gene that regulates its expression in the apical ectodermal ridge of the developing limb buds of transgenic mice. , 1995, Developmental biology.

[13]  J. Aubin,et al.  Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. , 2000, Medscape women's health.

[14]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[15]  S. Coppack,et al.  Adipose Tissue Leptin Production and Plasma Leptin Kinetics in Humans , 1996, Diabetes.

[16]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[17]  A. Parfitt,et al.  Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  R. Unger,et al.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Stein,et al.  Downregulation of cell growth and cell cycle regulated genes during chick osteoblast differentiation with the reciprocal expression of histone gene variants. , 1989, Biochemistry.

[20]  L. Bonewald,et al.  Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  S. Mochizuki,et al.  Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. , 1997, Biochemical and biophysical research communications.

[22]  S. Mochizuki,et al.  Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. , 1998, Endocrinology.

[23]  J. Wanson,et al.  Isolation and subfractionation on ficoll gradients of adult rat hepatocytes. Size, morphology, and biochemical characteristics of cell fractions , 1975, The Journal of cell biology.

[24]  T. Martin,et al.  Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. , 1999, Bone.

[25]  L. Dahl A Simple and Sensitive Histochemical Method for Calcium , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  B. Kwon,et al.  TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  K. Anselme,et al.  Comparative study of the in vitro characteristics of osteoblasts from paralytic and non-paralytic children , 2000, Spinal Cord.

[28]  M. Jensen,et al.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.

[29]  C. Newgard,et al.  Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. , 1998, The Journal of biological chemistry.

[30]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[31]  P. Marie,et al.  Temporal variation of c‐fos proto‐oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone , 1995, Journal of cellular biochemistry.

[32]  J B Lian,et al.  Expression of differentiated function by mineralizing cultures of chicken osteoblasts. , 1987, Developmental biology.

[33]  N. Hoggard,et al.  Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Stein,et al.  Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. , 1996, Endocrinology.

[35]  D. Breault,et al.  Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line pyla: Structure‐activity relations and signal transduction mechanisms , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  Cai Li,et al.  Leptin: a multifunctional hormone , 2000, Cell Research.

[37]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[38]  P. Marie,et al.  New factors controlling bone remodeling. , 2000, Joint, bone, spine : revue du rhumatisme.

[39]  L. Pénicaud,et al.  High expression of leptin by human bone marrow adipocytes in primary culture , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  P. Roberson,et al.  Transcriptional Activation of the p21 WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines , 1998, The Journal of Biological Chemistry.

[41]  Á. Ballabriga Morphological and physiological changes during growth: an update , 2000, European journal of clinical nutrition.

[42]  S. Akira,et al.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. , 1998, Journal of immunology.

[43]  P. Robey,et al.  Human bone cells in vitro. , 1985, Calcified tissue international.

[44]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[45]  Ramzi W. Nahhas,et al.  Leptin is inversely related to age at menarche in human females. , 1997, The Journal of clinical endocrinology and metabolism.

[46]  M. Atkinson,et al.  Loss of the Differentiated Phenotype Precedes Apoptosis of ROS 17/2.8 Osteoblast-Like Cells , 1998, Calcified Tissue International.

[47]  C. Newgard,et al.  Lipoapoptosis in Beta-cells of Obese Prediabeticfa/fa Rats , 1998, The Journal of Biological Chemistry.

[48]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[49]  G. Stein,et al.  Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[51]  G. Stein,et al.  Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone‐specific complex , 1997, Journal of cellular biochemistry.

[52]  J. Lian Bone formation : osteoblast lineage cells, growth factors, matrix proteins and the mineralization process , 1999 .

[53]  S. Manolagas Cellular and molecular mechanisms of osteoporosis , 1998, Aging.

[54]  D. Accili,et al.  Effect of activating and inactivating mutations of GS‐and Gi2‐alpha protein subunits on growth and differentiation of 3T3‐L1 preadipocytes , 1997, Journal of cellular biochemistry.

[55]  H. Rønningen,et al.  Surgically induced uremia in rats I: Effect on bone strength and metabolism , 1993, Bioscience reports.

[56]  P. Gregory Cellular and Molecular Biology of Bone , 1995 .

[57]  L. Pénicaud,et al.  Regulation by Cytokines of Leptin Expression in Human Bone Marrow Adipocytes , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[58]  G S Stein,et al.  Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. , 1993, Endocrine reviews.

[59]  C. Newgard,et al.  Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  B. Frenkel,et al.  Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. , 1997, Molecular endocrinology.

[61]  C. Steppan,et al.  A role for leptin in brain development. , 1999, Biochemical and biophysical research communications.

[62]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[63]  K. Nicolaides,et al.  The relationship between leptin concentration and bone metabolism in the human fetus. , 2000, The Journal of clinical endocrinology and metabolism.

[64]  E. Estey,et al.  Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. , 1999, Blood.